Sickle cell disease disproportionately affects babies in Africa, but many go undiagnosed due to lack of screening. Newborn screening is needed to save lives and improve care.

Novartis is collaborating with Microsoft to apply machine learning to medicinal chemistry — part of an effort to leverage AI to bring treatments to patients more efficiently.

Researchers around the world are collaborating to provide solutions to immediate and future challenges.

Novartis researchers have discovered a compound that is showing promise against three parasites that cause three neglected diseases.

An investigational treatment for an uncommon immunodeficiency disease races into clinical studies.